Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
ImmunoPrecise Antibodies has secured a collaboration with an undisclosed “leading biotech” to discover new antibody-drug ...
Panelists discuss how recent FDA approvals for bispecific antibodies in oncology, particularly for hematologic malignancies ...
Hosted on MSN25d
New antibody innovation looks to revolutionize cancer treatmentHowever, the new antibody design addresses these challenges. Its modular structure includes a bispecific antibody produced in bulk and a synthetic peptide tailored to individual tumors.
A Stanford-led team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its ...
Geoffrey Shouse, DO, PhD, discusses the growing interest in bispecific antibodies within the field of oncology.
Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...
DUBLIN--(BUSINESS WIRE)--The "PD-1 x VEGF and PD-L1 x VEGF Bispecific ... x VEGF bispecific antibodies regarding stakeholders, R&D pipeline, clinical profile and molecular structure of drug ...
Top-line Phase 2/3 data readout for COMPANION-002, evaluating tovecimig (CTX-009 - a DLL4 x VEGF-A bispecific antibody) in patients with biliary ...
Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody & Cancer Patent Landscape Analysis" report has been added to ResearchAndMarkets.com's offering. The development of bispecific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results